The Federal service for supervision in the sphere of health has completed the examination of the quality samples of the drug “Propofol Kabi, emulsion... Roszdravnadzor: the drug “Propofol” consistent quality and safety

The Federal service for supervision in the sphere of health has completed the examination of the quality samples of the drug “Propofol Kabi, emulsion for intravenous injection 20 mg/ml” series 16LK8819 and 16МВ9982 production Fresenius Kabi Austria GmbH, Austria.

Samples of the drug series 16LK8819 was withdrawn during carrying out quickly-search actions the “MADLANG” and “MEDICLINIC” in which this drug was used for plastic surgery patients. Samples of the drug series 16МВ9982 was selected by the Roszdravnadzor in the framework of a selective quality control of medicines for medical use into the “Central clinical hospital # 1 (branch NUZ “NCC JSC “RZD”) in connection with the identification of unexpected serious reactions in patients that are associated, perhaps with the use of drugs.

The examination of the seized samples, conducted at the Moscow testing laboratory quality control of medicines, Federal state budget institution “ICEWORM” Roszdravnadzor confirmed their compliance with the quality requirements in drug registration, informed in a press-service Roszdravnadzora, adding that the investigation of the causes of complications continues.

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *